UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): September 1, 2022

Live Ventures Incorporated

(Exact Name of Registrant as Specified in Charter)

Registrant’s telephone number, including area code: 702-997-5968

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Securities registered pursuant to Section 12(b) of the Act:

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

Item 7.01 Regulation FD Disclosure.

In accordance with Regulation FD, Live Ventures Incorporated (the “Company”) posted an “Investor Presentation” that the Company may present or otherwise make available to analysts and investors on or after September 1, 2022. Contemporaneously with the filing of this Current Report, the slides that comprise the Investor Presentation will be available on the Company’s website at liveventures.com. The information contained in the Investor Presentation is summary information that is intended to be considered only in the context of the Company’s periodic reports, as filed with Securities and Exchange Commission (“SEC”), and of other public announcements that the Company may make, by press release or otherwise, from time to time (collectively, the “Public Disclosures”).

If the Investor Presentation provides estimates or targets concerning fiscal 2022 or any subsequent years, these reflect statements that have previously been made in the Company’s Public Disclosures. The Company does not undertake any duty or obligation to disclose any updates or revisions in the information contained in the Investor Presentation, although the Company may do so from time to time. Any such updating may be made through the Company’s filing of periodic reports or documents with the SEC, through press releases, or through other Public Disclosure.

The slides that constitute the Investor Presentation are furnished as Exhibit 99.1. In accordance with General Instruction B.2 of Form 8-K, the information furnished pursuant to Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01. Financial Statements and Exhibits

(d) Exhibits.

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: September 6, 2022

3